Drugs / SPWCV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01537185 | Feb → Oct 2012 | — | PATH Vaccine Solutions | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SPWCV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01537185 ↗ |
| Known as | wSp | “Streptococcus pneumoniae whole cell vaccine (wSp) is an investigational vaccine that contains killed cells from a nonencapsulated strain of S. pneumoniae (SPn) with aluminum...” PMID 31895881 ↗ Apr 2020 |
| Modality | Vaccine | “Streptococcus pneumoniae whole cell vaccine (wSp) is an investigational vaccine” PMID 31895881 ↗ Apr 2020 |
| Route | Intramuscular | “0.1, 0.3, or 0.6 mg of wSp or saline intramuscularly” PMID 31895881 ↗ Apr 2020 |